MDCO - The Medicines Company (MDCO) CEO Mark Timney on Q2 2019 Results - Earnings Call Transcript
The Medicines Company (MDCO)
Q2 2019 Earnings Conference Call
July 24, 2019 08:30 AM ET
Company Participants
Krishna Gorti - Vice President, Investor Relations
Mark Timney - Chief Executive Officer
Christopher Visioli - Chief Financial Officer
Peter Wijngaard - Chief Development Officer
Conference Call Participants
Umer Raffat - Evercore ISI
Dae Gon - Leerink
Jessica Fye - JP Morgan
Joel Beatty - Citi
Chris Shibutani - Cowen and Company
Madhu Kumar - Robert W. Baird
Paul Choi - Goldman Sachs
Yasmeen Rahimi - Roth Capital Partners
Akash Tewari - Wolfe Research
Mayank Mamtani - B.